The Bio Report
A podcast by Levine Media Group - Wednesdays
563 Episodes
-
Restoring Immune Activity While Suppressing Cancer Proliferation
Published: 4/21/2022 -
A New Model for Preventing Life-Threatening Blood Clots
Published: 4/14/2022 -
The Race to Live Forever
Published: 4/7/2022 -
A Model for Moving from Breakthrough to Blockbuster
Published: 3/31/2022 -
Building the Next-Generation of Cell and Gene Therapies
Published: 3/24/2022 -
Building Small Molecule Drugs that Are Superior to Biologics
Published: 3/17/2022 -
A New Class of Cancer Therapies Targets Solid Tumors with a Dual Action
Published: 3/10/2022 -
A Pursuit of Off-The-Shelf CAR-T Therapies
Published: 3/3/2022 -
Mapping the Human Proteome
Published: 2/24/2022 -
Gene Therapy Provides Hope to Hemophilia B Patients
Published: 2/17/2022 -
Making Data-Driven Medicine a Reality
Published: 2/10/2022 -
A Neuroscientist Turned Venture Investor Discusses TechBio Investing
Published: 2/3/2022 -
A Nonprofit Seeks to Make Cell and Gene Therapies Affordable Worldwide
Published: 1/27/2022 -
Disposing Toxic Proteins to Treat Neurodegenerative Diseases
Published: 1/20/2022 -
Repurposing a Drug for Parasitic Infections as a Targeted GI Therapy
Published: 1/13/2022 -
Targeting Chronic, Low-Grade Inflammation to Address Diseases of Aging
Published: 1/6/2022 -
The Year in Biotech and What’s Ahead in 2022
Published: 12/30/2021 -
Restoring the Guardian of the Genome to Fight Tumors
Published: 12/23/2021 -
Advancing a Cell Therapy with the Potential to Cure HIV
Published: 12/16/2021 -
Harnessing More Efficient Organisms to Reshore BioManufacutring
Published: 12/9/2021
The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.